Steven O'Day - 18 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chief Medical Officer
Signature
/s/Christine Klaskin, as attorney-in-fact for Steven O'Day
Issuer symbol
AGEN
Transactions as of
18 Jun 2025
Net transactions value
+$194,432
Form type
4
Filing time
30 Jun 2025, 16:30:24 UTC
Previous filing
18 Nov 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Day Steven J Chief Medical Officer C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON /s/Christine Klaskin, as attorney-in-fact for Steven O'Day 30 Jun 2025 0001845281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $194,432 +43,497 +319% $4.47 57,116 18 Jun 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the executive's 2024 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 30-day lockup restriction with 100% of the award released on July 18, 2025.
F2 $4.47 is the closing price of our Common Stock on June 18, 2025, the stock issuance date.